Company Profile
Updated: 11-NOV-09Micromet Inc.
Public Company, Headquarters Location
6707 Democracy Blvd., Ste. 505, Bethesda, MD 20817-1100, United States
(240)752-1420, (240)752-1425 fax, www.micromet-inc.com/
Primary SIC: Biological Products Except Diagnostic, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Manufacturing: Drugs for combating cancer. Services: Research and development of pharmaceuticals for fighting cancer.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Be Smoke Free & Treatments of Cancer.
M2 Presswire; 12/8/2009; 1180 words; ...Inc. (PINKSHEETS: SFIO); Micromet, Inc. (Nasdaq: MITI) AssociatesFortune...Micromet, Inc. closed at $6.87 Monday...Leukemia NEW ORLEANS, Dec. 8 -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical...
MICROMET REPORTS ACQUISITION BY SENIOR VP FAGERBERG (Maryland)
US Fed News Service, Including US State News; 12/5/2009; 300 words; WASHINGTON, Dec. 5 -- Micromet Inc. (MITI), Bethesda, Md., has filed a Form 4 with the Securities and Exchange Commission noting the change in the beneficial...
Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Presented at American Society of Hematology Annual Meeting.
PR Newswire; 12/2/2009; 957 words; ...PRNewswire-FirstCall/ -- Micromet, Inc. , a biopharmaceutical company...please log on to http://www.micromet-inc.com/. It is recommended that...at the site of attack. About Micromet, Inc. Micromet, Inc. is a biopharmaceutical...
Bayer Schering Bites on BiTE Option for Micromet Antibody.
BIOWORLD Today; 12/2/2009; 794 words; Micromet Inc. locked in a $7.5 million fee and...the $6 million Bethesda, Md.-based Micromet received last January when it granted...forceid=49747).) Under their deal, Micromet will be responsible for the preclinical...
Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet.
PR Newswire; 12/1/2009; 1399 words; ...Md., Dec. 1 /PRNewswire-FirstCall/ -- Micromet, Inc. , a biopharmaceutical company developing novel...number of T cells at the site of attack. About Micromet, Inc. Micromet, Inc. is a biopharmaceutical company developing...
Recent News Articles
- Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Presented at American Society of Hematology Annual Meeting.
PR Newswire - December 02, 2009 - /C O R R E C T I O N -- Micromet, Inc./.
PR Newswire - September 21, 2009 - Micromet, Inc. Reports Second Quarter 2009 Financial Results.
PR Newswire - August 06, 2009 - Micromet, Inc. to Host Conference Call and Webcast to Report Second Quarter 2009 Financial Results on August 6, 2009.
PR Newswire - July 27, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning